A unique iridium(III) complex-based chemosensor for multi-signal detection and multi-channel imaging of hypochlorous acid in liver injury by Zhang, Feiyue et al.
Author’s Accepted Manuscript
A Unique Iridium(III) Complex-based
Chemosensor for Multi-Signal Detection and Multi-
Channel Imaging of Hypochlorous Acid in Liver
Injury
Feiyue Zhang, Xiaowen Liang, Wenzhu Zhang,
Yong-Lei Wang, Haolu Wang, Yousuf H.
Mohammed, Bo Song, Run. Zhang, Jingli Yuan
PII: S0956-5663(16)30953-8
DOI: http://dx.doi.org/10.1016/j.bios.2016.09.067
Reference: BIOS9179
To appear in: Biosensors and Bioelectronic
Received date: 10 August 2016
Revised date: 9 September 2016
Accepted date: 19 September 2016
Cite this article as: Feiyue Zhang, Xiaowen Liang, Wenzhu Zhang, Yong-Lei
Wang, Haolu Wang, Yousuf H. Mohammed, Bo Song, Run. Zhang and Jingli
Yuan, A Unique Iridium(III) Complex-based Chemosensor for Multi-Signal
Detection and Multi-Channel Imaging of Hypochlorous Acid in Liver Injury,
Biosensors and Bioelectronic, http://dx.doi.org/10.1016/j.bios.2016.09.067
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com/locate/bios
 1 
A Unique Iridium(III) Complex-based Chemosensor 
for Multi-Signal Detection and Multi-Channel 
Imaging of Hypochlorous Acid in Liver Injury 
Feiyue Zhang
a
, Xiaowen Liang
b
, Wenzhu Zhang
a*
, Yong-Lei Wang
c
, Haolu Wang
b
, Yousuf H. 
Mohammed
b
, Bo Song
a
, Run Zhang
d*
, Jingli Yuan
a
 
a
State Key Laboratory of Fine Chemicals, School of Chemistry, Dalian University of 
Technology, Dalian 116024, P. R China. 
b
Therapeutics Research Centre, School of Medicine, The University of Queensland, Princess 
Alexandra Hospital, Woolloongabba, QLD 4102, Australia. 
c
Applied Physical Chemistry, Department of Chemistry, KTH Royal Institute of Technology, 
SE-100 44 Stockholm, Sweden. 
d
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. 
Lucia, QLD 4072, Australia. 
 E-mail: wzhzhang@dlut.edu.cn  
 E-mail: r.zhang@uq.edu.au 
 
  
 2 
ABSTRACT 
Although hypochlorous acid (HOCl) has long been associated with a number of inflammatory 
diseases in mammalian bodies, the functions of HOCl in specific organs at abnormal conditions, 
such as liver injury, remain unclear due to its high reactivity and the lack of effective methods 
for its detection. Herein, a unique Ir(III) complex-based chemosensor, Ir-Fc, was developed for 
highly sensitive and selective detection of HOCl. Ir-Fc was designed by incorporating a 
ferrocene (Fc) quencher to a Ir(III) complex through a HOCl-responsive linker. In the presence 
of HOCl, the fast cleavage of Fc moiety in less than 1 second led to the enhancement of 
photoluminescence (PL) and electrochemical luminescence (ECL), by which the concentration 
of HOCl was determined by both PL and ECL analysis. Taking advantages of excellent 
properties of Ir(III) complexes, optical and electrochemical analyses of the response of Ir-Fc 
towards HOCl were fully investigated. Followed by the measurements of low cytotoxicity of Ir-
Fc by MTT analysis, one-photon (OP), two-photon (TP) and lifetime imaging experiments were 
conducted to visualise the generation of HOCl in live microphage and HepG2 cells, and in 
zebrafish and mouse, respectively. Furthermore, the generation and distribution of HOCl in liver 
cells and liver injury of zebrafish and mouse were investigated. The results demonstrated the 
applicability of Ir-Fc as an effective chemosensor for imaging of HOCl generation in 
mitochondria of cells and liver injury in vivo, implying the potential of Ir-Fc for biomedical 
diagnosis and monitoring applications.  
Graphic Abstract 
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A unique Ir(III) complex, Ir-Fc, was developed as a chemosensor for photoluminescence and 
electrochemical luminescence detection of HOCl with high sensitivity, specificity, and rapid 
optical response. The bioapplications of Ir-Fc were conducted in visualisation of endogenous 
HOCl generation in liver cells, and liver injury in zebrafish and mouse through one photon (OP), 
two photon (TP), and luminescence lifetime imaging.  
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1. INTRODUCTION 
Hypochlorous acid (HOCl) is a strong oxidant that has potent antibacterial properties, playing 
important roles in the mammalian immune defence system (Dickinson and Chang 2011; 
Rongvaux et al. 2014; Winterbourn 2008). In animal and human bodies, the generation of HOCl 
is driven by a heme-containing enzyme, myeloperoxidase (MPO) catalysed oxidation reaction of 
chloride ion (Cl
-
) and hydrogen peroxide (H2O2) in activated leukocytes (Dickinson and Chang 
2011; Lou et al. 2013; Sun et al. 2014; Xiao et al. 2015; Zhang et al. 2015b; Zhou et al. 2015). 
While endogenous generation of HOCl plays an important role in immune defence against 
microorganisms, it is also strongly associated with mediating tissues damage that has been 
recognised to cause or exacerbate a wide range of inflammatory diseases, such as lung, liver and 
kidney disease, atherosclerosis, neurodegenerative disorders, myocardial infarction, and cancer 
(Li et al. 2015; Wu et al. 2013; Xu et al. 2013; Zhang et al. 2015a; Zhu et al. 2014). Therefore, 
there has been an increasing interest in the investigation of generation, distribution, tissue 
concentration, and metabolism of HOCl in living organisms to understand its biological 
functions (Emrullahoglu et al. 2013; Xiao et al. 2015; Yang et al. 2011; Yuan et al. 2012; Zhao et 
al. 2016). It is well documented that HOCl is generated by neutrophils and diffuses into 
hepatocytes during hepaticinjury (Iwamoto et al. 2002; Panizzi et al. 2009). Even so, in-situ 
detection of HOCl in vivo, particularly in a specific organ condition, remains a challenge due to 
its high reactivity (short lifetime, diffusion distance < 20 m) with biological molecules and the 
existence of various antioxidants, such as glutathione (GSH), cysteine (Cys) in cells (Dickinson 
and Chang 2011; Meng et al. 2015; Winterbourn 2008; Yuan et al. 2015).  
Over the past few years, a number of approaches have been developed to monitor the 
generation of HOCl in living systems, including colorimetric, luminescent/fluorescent, 
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electrochemical and chromatographic methods (Best et al. 2013; Goswami et al. 2015; Panizzi et 
al. 2009; Wu et al. 2013; Xiao et al. 2012; Xu et al. 2013; Yuan et al. 2015; Zhang et al. 2015a; 
Zhang et al. 2013a; Zhou et al. 2015; Zhu et al. 2014). Of these methods, 
luminescence/fluorescence detection of HOCl using small molecular probes is becoming 
increasingly attractive due to its inherent advantages such as high sensitivity and specificity, 
rapid analysis, and easy management (Guo et al. 2013; Hu et al. 2014; Hu et al. 2016; Zhang et 
al. 2013b; Zhang et al. 2016). Furthermore, employing microscopy molecular bioimaging 
technique, small molecular luminescence probes can be extensively applied to visualise the 
generation of HOCl in-situ in vivo (Cao et al. 2015; Kenmoku et al. 2007; Xiao et al. 2015). 
Accordingly, many molecular luminescence probes have recently been developed for the 
detection and imaging of HOCl in biological systems through exploring specific HOCl-mediated 
oxidation-reduction reactions (Xiao et al. 2012; Zhang et al. 2013b; Zhu et al. 2014).  
Since each detection and imaging technology has its own consideration, molecular probes 
featuring multi-signal detection and multi-modal imaging are highly desirable to the design of 
chemosensors for HOCl detection in aqueous solutions and biological samples. This can be 
achieved by integrating HOCl-responsive groups with suitable luminophores, such as 
fluorescein, rhodamine, coumarin, cyanine, and metal complexes (Chen et al. 2016). Among 
various classes of luminophores, luminescent transition metal complexes, especially those of 
iridium(III) and ruthenium(II) complexes have attracted increasing interest in the development of 
responsive chemosensors and cell imaging probes due to their excellent photophysical, 
photochemical, and electrochemical properties (Chi et al. 2014; Coogan and Fernandez-Moreira 
2014; Lo et al. 2012; Ma et al. 2012; Martin et al. 2014; Zhao et al. 2010).  
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In our previous works, several Ru(II) complex-based chemosensors for key biological 
markers, such as reactive oxygen/nitrogen species (ROS/RNS), amino acids and metal ions, have 
been developed and successfully applied to luminescent biosensing and bioimaging (Li et al. 
2015; Zhang et al. 2010a; Zhang et al. 2012a; Zhang et al. 2010b). Multi-signal detection of 
these biomarkers through photoluminescence (PL) and electrogenerated chemiluminescence 
(ECL) has also been demonstrated by tuning emission properties of these complexes via different 
sensing mechanisms, such as photo-induced electron transfer (PET) (Li et al. 2015; Zhang et al. 
2012a). Nevertheless, probes with multi-modal imaging of HOCl evolution in biological 
samples, especially in diseased models, have not been well developed. Moreover, imaging 
conducted by one-photon microscopy (OPM) requires a rather shorter excitation wavelength, 
which prevents their application in live tissue imaging because of the shortcomings of shallow 
penetration depth, and photo-damage to biological samples (Li et al. 2015; Liang et al. 2016; 
Yuan et al. 2015).  
Cyclometalated Ir(III) complexes exhibit favourable photophysical properties (Coogan and 
Fernandez-Moreira 2014; Lo 2015; Ma et al. 2012; Ru et al. 2015; Zhao et al. 2010), including: 
i) high photostability, which enables real-time monitoring of targets without photobleaching; ii) 
large Stokes shift, which can minimise the possibility of self-quenching; iii) long luminescence 
lifetime, which allows them to be used for lifetime imaging and even time-gated luminescence 
imaging; iv) -conjugated ligands, which endow them two-photon absorption behaviour, and to 
be used for two-photon (TP) bioimaging; v) abundant electrochemical properties, which suggest 
them being used in ECL detection; vi) low cytotoxicity, which provides them good application in 
biological samples. Therefore, these facts encourage us to engineer an Ir(III) complex-based 
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chemosensor for multi-signal detection of HOCl and multi-modal imaging of HOCl in biological 
systems. 
Considering the effective triplet state quenching of ferrocene (Cao et al. 2015; Shu et al. 
2012), and the excellent photophysical properties of cyclometalated Ir(III) complexes, in the 
present work, a unique Ir(III) complex-based chemosensor, Ir-Fc, was developed for rapid PL 
and ECL detection of HOCl. Ir-Fc was designed and synthesized by conjugation of ferrocene 
quencher and Ir(III) complex through a HOCl-sensitive hydrazine linker (Scheme 1). The 
produced chemosensor, Ir-Fc, is weakly luminescent in both PL and ECL analysis due to the 
presence of PET process. The specific cleavage of ferrocenyl quencher from the Ir-Fc mediated 
by HOCl led to the emission enhancement of the chemosensor, by which Ir-Fc was expected to 
be used for PL and ECL switch-ON sensing of HOCl. The cleavage of ferrocenyl by HOCl was 
then confirmed by the electrochemical test, including differential pulse voltammetry (DPV) and 
cyclic voltammograms (CVs) analysis. To demonstrate the broad bioapplications of Ir-Fc, HOCl 
generation in RAW 264.7 and HepG2 cells, and in livers of zebrafish and mouse was imaged by 
OPM, TPM and fluorescence lifetime imaging microscopy (FLIM). To the best of our 
knowledge, Ir-Fc is the first example of PL and ECL chemosensor for HOCl detection in injury 
cells and abnormal animal organs. 
<Scheme 1 is here> 
2. EXPERIMENTAL SECTION 
2.1 Synthesis of Ir-Fc 
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A mixture of [Ir(ppy)2Cl]2 (116 mg, 0.1 mmol) and ligand bpy-Fc (88 mg, 0.2 mmol) was 
suspended in 30 mL CH3OH/CH2Cl2 (2:1, v/v) and heated at 60 
o
C under Ar atmosphere. After 
refluxing for 6 h with stirring, the solvent was evaporated under reduced pressure, and the crude 
product was purified by silica gel column chromatography with CH2Cl2-MeOH as eluent. The 
product, Ir-Fc, was collected and isolated as its hexafluorophosphate salt. Yield: 70.2%. ESI-MS 
(m/z): 941.2. 
1
H NMR (400 MHz, CD3CN): δ 8.88 (s, 1H), 8.53 (s, 1H), 8.13 (d, J = 5.7Hz, 1H), 
8.07 (d, J = 8.4Hz, 2H), 7.90-7.75 (m, 6H), 7.62 (dd, J = 12.6, 5.3Hz, 2H), 7.37 (d, J = 5.4Hz, 
1H), 7.11-7.00 (m, 4H), 6.93 (tdd, J = 7.4, 4.6, 1.2Hz, 2H), 6.28 (dd, J = 12.4, 7.3Hz, 2H), 4.78 
(s, 2H), 4.45 (s, 2H), 4.33 (s, 5H), 2.55 (s, 3H). 
13
C NMR (126 MHz, CD3CN): δ 169.49 , 167.15 
, 162.92 , 156.90, 154.51 , 151.96, 151.25, 149.97-149.51 , 148.99 , 143.79 , 141.66 , 138.32, 
131.26, 130.13, 129.20, 125.41, 124.63 , 123.24, 122.64-121.76 , 119.62, 116.98, 72.52, 70.79, 
69.71, 68.13 , 20.16. Elemental analysis calcd. (%) for C45H36F6FeIrN6O2P∙H2O: C 48.96, H 
3.47, N 7.61; found (%): C 49.03, H 3.34, N 7.74.  
2.2 Synthesis of Ir-COOH 
A mixture of [Ir(ppy)2Cl]2 (116 mg, 0.1 mmol) and bpy-COOH ligand (43 mg,0.2 mmol) was 
suspended in 30 mL CH3OH/CH2Cl2 (2:1, v/v) and heated at 65 
o
C under Ar atmosphere. After 
refluxing for 6 h with stirring, the solvent was evaporated under reduced pressure, and the crude 
product was purified by silica gel column chromatography with CH2Cl2-MeOH as eluent. The 
product, Ir-COOH, was then collected and isolated as its hexafluorophosphate salt. Yield: 
59.1%. ESI-HRMS (m/z): 715.1685, 737.1502 (M+Na). 
1
H NMR (400 MHz, CD3CN): δ 8.96 (s, 
1H), 8.52 (s, 1H), 8.10-8.01 (m, 2H), 7.95 (d, J = 5.5 Hz, 1H), 7.89-7.85 (m, 1H), 7.85-7.75 (m, 
5H), 7.60 (d, J = 5.8 Hz, 2H), 7.30 (d, J = 5.7 Hz, 1H), 7.06-6.97 (m, 4H), 6.91 (t, J = 7.4 Hz, 
2H), 6.34-6.23 (m, 2H), 2.53 (s, 3H). 
13
C NMR (126 MHz, CDCl3): δ 168.09, 166.76, 156.12, 
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155.08, 151.66, 150.57,150.15, 149.76, 148.43, 148.13, 143.43, 138.09, 131.76, 130.91, 128.65, 
128.44, 125.25, 124.89, 124.53, 123.12, 122.70, 119.78, 119.62, 21.59.  
3. RESULTS AND DISCUSSION 
3.1 Synthesis and characterization of Ir-Fc for HOCl 
As shown in Fig. S1, Ir-Fc was synthesized by a two-step reaction. Briefly, the synthesized 
ligand, bpy-Fc, was refluxed with [Ir(ppy)2Cl]2 in CH3OH/CH2Cl2 (v/v 2:1) for 6 h, the formed 
Ir-Fc was then purified by chromatography to give a 70.2% yield of Ir-Fc. Ir-COOH was 
synthesized and purified by a similar procedure. Structures of Ir-Fc and Ir-COOH were 
confirmed by NMR, MS (Fig. S2-S7), and elemental analysis. In addition, to verify the 
production of Ir-COOH after the reaction of Ir-Fc with HOCl, in-situ ESI-MS analysis was 
performed for the reaction solution. As shown in Fig. S8, the molecular-ion peak at m/z 715.3 
was assigned to the [Ir(ppy)2(COOH-bpy)]
+
, indicating the successful cleavage of the ferrocenyl 
moiety quencher by HOCl and the generation of Ir-COOH.  
As expected, Ir-Fc displayed weak emission due to the effective PET (Fig. S9), and the 
luminescence quantum yield () was determined to be 0.0069. In the presence of HOCl, strong 
luminescence emission centered at 600 nm was observed with luminescence quantum yield () 
of 0.11. The emission lifetime of Ir-Fc was determined to be 4.44 ns (Zhang et al. 2012b), while 
that of Ir-COOH was significantly increased to 90.52 ns. Such result in the changes of emission 
lifetime suggested that Ir-Fc could be used as a potential probing reagent for lifetime imaging of 
HOCl in biological systems. UV-Vis absorptions of Ir-Fc and Ir-COOH were also measured 
(Fig. S10). Ir-Fc showed strong absorption at 280-320 nm which can be assigned to the spin-
allowed intraligand transition of ppy and the functionalized bpy ligand, while the absorption 
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bands in the visible region could be attributed to the overlap of the spin-allowed metal-to-ligand 
charge transfer (MLCT), ligand-to-ligand charge transfer (LLCT), and the d-d absorption band of 
ferrocene (around 460 nm). 
3.2 PL response of Ir-Fc towards HOCl 
As shown in Fig. 1A, Ir-Fc displayed weak and stable luminescent emission at 600 nm. Upon 
addition of HOCl, rapid luminescence enhancement was observed within 1 second, and then the 
luminescence intensity reached a steady level. The addition of another amount of HOCl induced 
similar enhancement in the luminescence intensity. These results suggest that Ir-Fc can truly 
serve as a chemosensor for rapid HOCl detection, which is one of the key requirements for a 
biosensor to be used in the monitoring of HOCl in vivo. 
As shown in Fig. 1B, PL intensity of Ir-Fc was gradually increased upon the addition of 
HOCl, and the maximum PL intensity was observed in the presence of 20 equiv. of HOCl. By 
plotting the luminescence intensity against HOCl concentration, a linear correlation can be 
obtained in the range of 5-40 M (Fig. 1C). The detection limit, calculated according to the 
method defined by IUPAC (Mocak 1997), is 93.3 nM, which indicates that Ir-Fc can be used as 
a sensitive chemosensor for the quantification of HOCl. 
Specificity of PL response of Ir-Fc towards HOCl was examined, and the result was shown 
in Fig. 1D. No obvious PL enhancement was observed upon the additions of competitive 
ROS/RNS (including ∙OH, H2O2, O2
-
, 
1
O2, ONOO
-
, NO3
-
, NO2
-
, and NO) and biologically 
relevant metal ions (including Mg
2+
, Fe
2+
, Zn
2+
, Fe
3+
, Mn
2+
, Na
+
, K
+
, Ni
2+
, Cd
2+
, Co
2+
, Pb
2+
 and 
Cu
2+
). In contrast, a remarkable enhancement in PL intensity was observed in the presence of 
HOCl, demonstrating the specific PL response of Ir-Fc towards HOCl. Such a specific PL 
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response enables Ir-Fc to be further useful as a luminescent chemosensor for imaging of HOCl 
in complicated biological samples.  
<Fig. 1 is here> 
The effect of pH on the PL response of Ir-Fc towards HOCl was determined. As shown in 
Fig. S13, in the absence of HOCl, the luminescence intensity of Ir-Fc was weak and stable in the 
range of pH 3-11. However, upon the addition of HOCl to the PBS solution containing Ir-Fc, PL 
intensities were remarkably increased. The slight decrease in luminescence intensities at acidic 
conditions could be attributed to the protonation of the carboxyl group of Ir-COOH. Since the 
dissociation of HOCl to hypochlorite anions (OCl
-
) (pKa = 7.463 at 35 
o
C) (Zhang et al. 2013a), 
the HOCl-mediated oxidation reaction with hydrazine moiety could be partly blocked, which 
resulted in the diminishing of luminescence intensities at pH 8-11. 
3.3 Electrochemical and ECL responses of Ir-Fc towards HOCl 
As redox parameters critical to ECL, the cyclic voltammograms (CVs) of Ir-Fc and Ir-COOH 
were firstly characterized. As shown in Fig. S14, both complexes underwent irreversible 
oxidations. The CVs of Ir-Fc were characterized by 2 major electron oxidation peaks around 
E
ox
1/2 = 1.18 V (vs Ag/AgCl) and E
ox
1/2 = 0.42 V (vs Ag/AgCl), which could be assigned to the 
Ir
III
/Ir
IV
 and Fc
0
/Fc
I
 redox couples (Donato et al. 2013; Shu et al. 2012). Similar to Ir-Fc, a one-
electron oxidation wave of Ir
III
/Ir
IV
 of Ir-COOH was determined to be E
ox
1/2 = 1.15 V (vs 
Ag/AgCl). In addition, the onset potentials (E
ox
onset) of the Ir
III
/Ir
IV
 for Ir-Fc and Ir-COOH were 
also determined to be around 1.07 V and 1.05 V (vs Ag/AgCl), respectively. The close 
correspondence of the E
ox
1/2 for Ir
III
/Ir
IV
 of Ir-Fc and Ir-COOH suggested that the Ir
III
 centre 
was not greatly perturbed by the substitution of the bpy ligand of the complexes. Interestingly, it 
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was observed that the Fc
0
/Fc
I
 redox couple disappeared when Ir-Fc was transferred to Ir-
COOH, indicating the cleavage of Fc moiety. 
As shown in Fig. S15A, upon the addition of HOCl, the one-electron oxidation wave (E
ox
1/2) 
of Fc
0
/Fc
I
 redox couple was gradually weakened. The electrochemical response of Ir-Fc as a 
function of the added HOCl concentration was also examined by using the differential pulse 
voltammetry (DPV) measurement, by which a better-resolved potential information could be 
obtained. As shown in Fig. S15B, the one-electron oxidation peak of Fc
0
/Fc
I
 couple was 
obtained, accompanied by shoulder at 0.61 V (vs Ag/AgCl), which could be assigned to the 
redox potential of the ligand. In increasing amount of HOCl, the cleavage of the hydrazine 
moiety led to the diminishing of Fc
0
/Fc
I
 oxidation potential, and no DPV peak of Fc
0
/Fc
I
 couple 
was observed for Ir-COOH. 
Although Ir(III) complexes have been extensively investigated in photophysics and 
photochemistry, their utilizations for ECL molecular sensing, especially for the multi-signal 
sensing combination of PL and ECL are rarely explored. As shown in Fig. S16, the ECL signal 
of Ir-Fc was extremely low, while Ir-COOH, the reaction product of Ir-Fc with HOCl, showed 
strong ECL emission. Most likely, the weak ECL of Ir-Fc can be attributed to the lack of ECL 
excited state of *Ir
III
 in the presence of ferrocenyl moiety, while the recovery of strong ECL of 
Ir-COOH is caused by the cleavage of ferrocenyl moiety in the Ir(III) complex (Lin et al. 2010). 
As shown in Fig. 2A, the ECL intensity of Ir-Fc was gradually increased upon the additions of 
different concentrations HOCl in PBS buffer containing 10 mM of TPrA. A good linearity was 
obtained in the range of 2.5-25 M of HOCl concentration. The detection limit, calculated 
according to the method defined by IUPAC (Mocak 1997), is 0.28M. As shown in Fig. 2B, 
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strong ECL emission could only be observed when Ir-Fc was reacted with HOCl, corroborating 
the results of highly selective detection of HOCl. 
<Fig. 2 is here> 
3.4 Theoretical calculations 
To further understand the photophysical properties, electron transition and the luminescence 
response of Ir-Fc in the presence of HOCl, density functional theory (DFT) and time-dependent 
DFT (TD-DFT) calculations were performed to estimate the corresponding transition energy of 
Ir-Fc and Ir-COOH based on the ground-state and excited-state geometries. Low-lying triplet 
excited states of Ir-Fc and Ir-COOH were then optimised by TD-DFT method to investigate the 
turn-ON luminescence changes, and the calculated data are shown in Fig. S21 and Table S3. 
Lowest-energy triplet excited state (T1) of Ir-COOH was contributed from HOMO → LUMO, 
which can be attributed to the emissions of 
3
MLCT and 
3
LLCT, as has usually been 
demonstrated in the Ir(III) complexes (Ru et al. 2014; Sharma et al. 2014; Xiong et al. 2010). In 
contrast, the inefficient luminescence emission of Ir-Fc may be assigned to the 
3
ILCT, 
3
LMCT 
and 
3
LLCT based on HOMO-1 → LUMO+7 and HOMO → LUMO+9. These transitions may be 
attenuated by the electron transfer from Fc moiety to bpy ligand, leading to the luminescence 
quenching of Ir-Fc (Sharma et al. 2014). This feather of lack of excited state is in parallel with 
the electrochemical analysis for Ir-Fc. Therefore, the calculation data strongly supported the 
turn-ON luminescence of Ir-Fc upon interaction with HOCl. 
The possibility of electron transfer process of Ir-Fc was then examined by the 
thermodynamic criteria, the free energy changes (∆GPET) of the PET effect, which was calculated 
using Rehm-Weller equation (Zhang et al. 2009). The free energy changes ∆GPET was 
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determined to be -23.335 kJ mol
-1
 (-0.242 eV) by DFT calculation, and -37.036 kJ mol
-1
 (-0.384 
eV) based on the measurement of absorption edge (Wang et al. 2012). Given that negative ∆GPET 
represents the thermodynamical possibility of electron transfer, negative value of ∆GPET obtained 
by both DFT calculation and experiments clearly demonstrated that electron transfer may occur 
for Ir-Fc. 
3.5 Imaging of HOCl generation in biological systems 
Prior to visualization of HOCl in living organisms, the cytotoxicity of Ir-Fc was evaluated on the 
basis of the reduction activity of methyl thiazolyltetrazolium (MTT) assay. In the current study, 
mouse microphage (RAW 264.7) and HepG2 cells were selected for the cytotoxicity evaluation. 
As shown in Fig. S22, the cell viabilities are all greater than 90% after exposure of 150 M of 
Ir-Fc for 24 h, suggesting that the Ir-Fc has good biocompatibility.  
Increased generation of reactive oxygen species (ROS), including HOCl, has long been 
observed in cancer cells, while the HOCl generation during cancer chemotherapy is less clear 
(Trachootham et al. 2009). Thus, we next investigated the HOCl generation in HepG2 cells upon 
treatment with anticancer drug, elesclomol. As shown in Fig. 3, Ir-Fc-loaded HepG2 cells 
exhibited almost no luminescence, while the intracellular luminescence was significantly 
increased when the cells were further incubated with elesclomol. These results suggested that the 
endogenous HOCl generation in HepG2 cells during chemotherapy could be detected by 
employing Ir-Fc as a sensing probe. 
<Fig. 3 is here> 
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It was noticed that the intracellular luminescence of Ir-Fc-loaded HepG2 cells was presented 
partly in the cytoplasm (Fig. 3F). This observation attracted our attention to investigate the 
subcellular localization of Ir-Fc in HepG2 cells using laser-scanning confocal microscopy. Since 
it has been known that Ir(III) complexes can cross the membrane to be accumulated in the 
mitochondria (Chen et al. 2014; Sun et al. 2016), co-localization experiments of Ir-Fc and 
mitochondria were carried out for HepG2 cells. As shown in Fig. S24 and S25, red luminescence 
of Ir-Fc was significantly co-localized with the green luminescence of MitoTracker green, 
confirming that Ir-Fc molecules were distributed in mitochondria of cancer cells. The intensity 
correlation quotients (ICQ) for two stains was determined to be 0.392, which is close to 0.5, 
suggesting that the stains of Ir-Fc and MitoTracker green are dependent. Both the Pearson’s 
correlation coefficient (0.884) and the Mander’s overlap coefficient (0.892) are close to 1, 
indicating the mitochondria distribution of red luminescence of Ir-Fc in HepG2 cells. 
Ir-Fc was then applied to visualize endogenous HOCl production during drug stimulation in 
live zebrafish. In a control group, Zebrafish showed almost non-luminescence upon incubation 
with Ir-Fc alone for 2 h (Fig. S27). In contrast, as shown in Fig. 4, bright red luminescence was 
observed when zebrafish was stimulated with LPS and treated with Ir-Fc for 2 h, respectively. 
Importantly, it was noticed that the luminescence mainly localized in the liver of zebrafish, 
suggesting the endogenous HOCl generation in liver tissue (Li et al. 2015). It is well known that 
LPS can cause liver injury as an endotoxin, as the consequence, the increase of HOCl generation 
induced by the endotoxic shock can be confirmed by employing Ir-Fc as a HOCl sensing probe 
(Li et al. 2015). 
<Fig. 4 is here> 
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Next, we demonstrated the two-photon (TP) imaging of HOCl generation induced by 
ischemia-reperfusion (I/R) injury in fresh mouse liver tissue. Mouse hepatic artery was clamped 
by using a microvascular clamp for 0.5 h, followed by reperfusion in the liver for 2 h. As shown 
in Fig. 5, a significant increase in red emission was observed in hepatocytes with decreased 
autofluorescence in I/R liver. The enhancement of luminescence intensity is due to the HOCl 
generation during hepatic I/R injury, which has been well documented. The result indicated the 
feasibility of detection of HOCl generation in living liver tissue by utilizing Ir-Fc as a TP 
imaging probe. 
<Fig. 5 is here> 
The increase of luminescence lifetime upon detection of HOCl promoted us to map the 
changes of lifetime by lifetime imaging in fresh liver tissues. The luminescence lifetime of Ir-Fc 
in normal liver tissue was measured as ca. 1.9 ns, while it was significantly increased to 65.6 ns 
in I/R injury liver (Fig. S28, S29). In consistence with the result of lifetime measurement in 
buffer solution, the increase in luminescence lifetime could be attributed to the formation of Ir-
COOH, the reaction product of Ir-Fc with HOCl in the I/R injury liver. In addition, it was 
noticed that the luminescence lifetime of Ir-Fc in liver showed 2.5 ns shorter than that in buffer 
solution, which might be due to the effects of solvents and surroundings of the sensor molecules.  
4. CONCLUSIONS 
In the present work, a unique Ir(III) complex, Ir-Fc, was designed and synthesized for the 
detection of HOCl in aqueous and biological media. Ir-Fc showed almost non-luminescence in 
both PL and ECL due to the presence of effective PET process, while its emission was 
remarkably enhanced by a HOCl-mediated cleavage reaction, by such a mechanism the 
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quantification of HOCl could be achieved. The results of optical and electrochemical 
measurements indicated that Ir-Fc could be used as a multi-signal chemosensor for highly 
sensitive and selective detection of HOCl in less than 1 second. The cell experimental results 
revealed that Ir-Fc was low cytotoxic, and could be used as a luminescent sensing probe for 
imaging of HOCl in biological samples. Further experiments on visualisation of HOCl in livers 
of zebrafish and mouse demonstrated that Ir-Fc was suitable to be used for monitoring of HOCl 
generation in liver injury. The advances of the present HOCl chemosensor could not only 
highlight the application value of luminescence metal complexes in biosensing and bioimaging, 
but also could open a new field for the application of chemosensors in disease diagnosis and 
monitoring. It is also believed that the successful applications of Ir-Fc for HOCl sensing and 
bioimaging have the potential to advance the fields of current analytical science and 
biomedicine. 
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Scheme 1. Design of the luminescent chemosensor, Ir-Fc, for selective and sensitive detection 
of HOCl. 
Fig. 1. PL response of Ir-Fc towards HOCl. (A) Time course of the luminescence response of 
Ir-Fc (10M) towards HOCl addition (final concentration of 7.5 M for each). (B) Excitation 
and emission spectra of Ir-Fc (10 ) in the presence of various concentrations of HOCl (0, 5, 
10, 15, 20, 25, 30, 40, 60, 80, 100, 150 and 200 M). (C) Calibration curve for HOCl detection 
using Ir-Fc (10 M) as a sensing probe. (D) PL intensities of Ir-Fc (10 M) in the presence of 
different bioactive species (100 M). (a) blank, (b) HOCl, (c) ·OH, (d) H2O2, (e)O2
-
, (f) 
1
O2, (g) 
ONOO
-
, (h)NO2
-
, (i) NO3
-
, (j) NO, (k) Fe
2+
, (l) metal ions (100M for each, including Mg2+, 
Zn
2+
, Fe
3+
, Mn
2+
, Na
+
, K
+
, Ni
2+
, Cd
2+
, Co
2+
, Pb
2+ 
and Cu
2+
).  
Fig. 2. (A) ECL responses of Ir-Fc (10 M) towards various concentrations of HOCl ( 0, 2, 5, 
10, 15, 20, and 25M) in 25 mM PBS-EtOH (1:1, v/v) buffer of pH 7.4 containing 10 mM TPrA 
(the inset shows the calibration curve for the ECL detection of HOCl). Scan rate of ECL was 
0.15 V/s. (B) ECL intensities of Ir-Fc (10 M) in the presence of different bioactive species 
(100 M). (a) blank, (b) HOCl, (c) ·OH, (d) H2O2, (e) O2
-
, (f) 
1
O2, (g) ONOO
-
, (h) NO2
-
, (i) NO3
-
, (j) NO, (k) Fe
2+
, (l) metal ions (including Mg
2+
, Zn
2+
, Fe
3+
, Mn
2+
, Na
+
, K
+
, Ni
2+
, Cd
2+
, Co
2+
, 
Pb
2+ 
and Cu
2+
).  
Fig. 3. Confocal luminescence imaging of HOCl generation in HepG2 cells during 
chemotherapy. (A) and (E) Bright-field images of HepG2 cells before and after treatment with 
elesclomol. (B) Luminescence image of the Ir-Fc-loaded cells. (F) Luminescence image of the 
Ir-Fc-loaded cells that were further treated with elesclomol for another 3 h. (C) and (G) Image J 
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3-D interactive intensity analysis of luminescence images of (B) and (F). (D) and (H) Merged 
images of (B) and (F) with their bright-field images. Scale bar: 10m.  
Fig. 4. Bright-field (A), luminescence (B) and merged (C) images of LPS (2 g/mL) pre-treated 
zebrafish incubated with 100 M Ir-Fc for 2 h. 
Fig. 5. Detection of ischemia-reperfusion (I/R) injury-induced HOCl production using Ir-Fc as a 
TP sensing probe in mouse liver under TP microscope. Scale bar: 40 μm. 
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Scheme 1. 
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Fig. 5.  
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